Jamanetwork
Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis
This cohort study investigates if anti-CD20 treatment is associated with an increase in the risk of inflammatory bowel disease in individuals with multiple sclerosis (MS).
625000
10
1h
119
12h
238
24h
476
48h
0%
ER
| First 24 hours | ||
|---|---|---|
| Hour | Growth | Total |
| 23:04+1h | +10 | 10 |
| 00:04+2h | +10 | 20 |
| 01:04+3h | +10 | 30 |
| 02:04+4h | +10 | 40 |
| 03:04+5h | +10 | 50 |
| 04:04+6h | +10 | 60 |
| 05:04+7h | +9 | 69 |
| 06:04+8h | +10 | 79 |
| 07:04+9h | +10 | 89 |
| 08:04+10h | +10 | 99 |
| 09:04+11h | +10 | 109 |
| 10:04+12h | +10 | 119 |
| 11:04+13h | +10 | 129 |
| 12:04+14h | +10 | 139 |
| 13:04+15h | +10 | 149 |
| 14:04+16h | +10 | 159 |
| 15:04+17h | +10 | 169 |
| 16:04+18h | +10 | 179 |
| 17:04+19h | +9 | 188 |
| 18:04+20h | +10 | 198 |
| 19:04+21h | +10 | 208 |
| 20:04+22h | +10 | 218 |
| 21:04+23h | +10 | 228 |
| 22:04+24h | +10 | 238 |
| By day | ||
|---|---|---|
| Date | Growth | Total |
| Thu, Oct 22 | +238 | 238 |
| Fri, Oct 23 | +238 | 476 |
| Sat, Oct 24 | +149 | 625 |
| Sun, Oct 25 | 0 | 625 |
| Mon, Oct 26 | 0 | 625 |
| Tue, Oct 27 | 0 | 625 |
| Wed, Oct 28 | 0 | 625 |
| Thu, Oct 29 | 0 | 625 |
| Fri, Oct 30 | 0 | 625 |
| Sat, Oct 31 | 0 | 625 |
| Sun, Nov 1 | 0 | 625 |
| Mon, Nov 2 | 0 | 625 |
| Tue, Nov 3 | 0 | 625 |
| Wed, Nov 4 | 0 | 625 |
| Thu, Nov 5 | 0 | 625 |